Forcyte Biotechnologies

Discover drugs that control how much cells "squeeze" to treat disease

Los Angeles, United States · Founded 2017 · $2.4M raised

Employees
1–10
Founded
2017
Total Funding
$2.4M
Last Round
$394K SeedJun 2022
Rounds
5

About

In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.

Summary

Forcyte Biotechnologies is a Drug Discovery company based in Los Angeles, United States, founded in 2017. It has raised $2.4M in total across 5 rounds, most recently a $394K Seed round in Jun 2022. Investors include Y Combinator, Pioneer Fund and Acequia Capital.

Funding History

SeedSeed RoundJun 2022

Sign up to see all 5 rounds

Grant through Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Forcyte Biotechnologies on Indexed.vc
<a href="https://indexed.vc/companies/forcyte-biotechnologies-inc"><img src="https://indexed.vc/api/badge/company/forcyte-biotechnologies-inc" alt="Forcyte Biotechnologies on Indexed.vc" width="260" height="76" /></a>